Group A streptococcal phagocytosis resistance is independent of complement factor H and factor H-like protein 1 binding

被引:38
作者
Kotarsky, H
Gustafsson, M
Svensson, HG
Zipfel, PF
Truedsson, L
Sjöbring, U
机构
[1] Lund Univ, Biomed Ctr, Inst Lab Med, Sect Microbiol Immunol & Glycobiol, S-22184 Lund, Sweden
[2] Hans Knoell Inst Nat Prod Res, Dept Infect Biol, Jena, Germany
关键词
D O I
10.1046/j.1365-2958.2001.02496.x
中图分类号
Q5 [生物化学]; Q7 [分子生物学];
学科分类号
071010 ; 081704 ;
摘要
Factor H (FH) and factor H-like protein 1 (FHL-1) regulate complement activation through the alternative pathway. Several extracellular bacterial pathogens, prime targets for the complement system, bind FH and FHL-1, thereby acquiring a potential mechanism for minimizing complement deposition on their surface. For group A streptococci (GAS), surface-bound antiphagocytic M proteins mediate the interaction. To study the role of the FH-FHL-1 interaction for complement deposition and opsonophagocytosis of GAS, we first constructed a set of truncated M5 protein variants and expressed them on the surface of a homologous M-negative GAS strain. Binding experiments with the resulting strains demonstrate that the major FH-FHL-1 binding is located in a 42-amino-acid region within the N-terminal third of M5. Measurement of bacteria-bound complement factor C3 after incubation in plasma showed that the presence of this region had little impact upon complement deposition through the alternative pathway. Moreover, streptococci expressing M5 proteins lacking the major FH and FHL-1 binding sequence resisted phagocytosis in human blood as efficiently as bacteria expressing the wild-type protein. Consequently, the data suggest that the binding of the regulators of the alternative pathway is of limited importance for GAS phagocytosis resistance.
引用
收藏
页码:817 / 826
页数:10
相关论文
共 42 条
[1]  
CAPARON MG, 1991, METHOD ENZYMOL, V204, P556
[2]   Streptococcus pyogenes serotype M1 encodes multiple pathways for entry into human epithelial cells [J].
Cue, D ;
Dombek, PE ;
Lam, H ;
Cleary, PP .
INFECTION AND IMMUNITY, 1998, 66 (10) :4593-4601
[3]   A nonpeptide integrin antagonist can inhibit epithelial cell ingestion of Streptococcus pyogenes by blocking formation of integrin α5β1-fibronectin-M1 protein complexes [J].
Cue, D ;
Southern, SO ;
Southern, PJ ;
Prabhakar, J ;
Lorelli, W ;
Smallheer, JM ;
Mousa, SA ;
Cleary, PP .
PROCEEDINGS OF THE NATIONAL ACADEMY OF SCIENCES OF THE UNITED STATES OF AMERICA, 2000, 97 (06) :2858-2863
[4]   LOCALIZATION OF PROTECTIVE EPITOPES OF THE AMINO TERMINUS OF TYPE-5 STREPTOCOCCAL M-PROTEIN [J].
DALE, JB ;
BEACHEY, EH .
JOURNAL OF EXPERIMENTAL MEDICINE, 1986, 163 (05) :1191-1202
[5]   INTRANASAL IMMUNIZATION WITH RECOMBINANT GROUP-A STREPTOCOCCAL M-PROTEIN-FRAGMENT FUSED TO THE B-SUBUNIT OF ESCHERICHIA-COLI LABILE TOXIN PROTECTS MICE AGAINST SYSTEMIC CHALLENGE INFECTIONS [J].
DALE, JB ;
CHIANG, EC .
JOURNAL OF INFECTIOUS DISEASES, 1995, 171 (04) :1038-1041
[6]  
Diaz A, 1997, J IMMUNOL, V158, P3779
[7]  
DiScipio RG, 1998, J IMMUNOL, V160, P4057
[8]   Factor H binding to bone sialoprotein and osteopontin enables tumor cell evasion of complement-mediated attack [J].
Fedarko, NS ;
Fohr, B ;
Robey, PG ;
Young, MF ;
Fisher, LW .
JOURNAL OF BIOLOGICAL CHEMISTRY, 2000, 275 (22) :16666-16672
[9]   LOCATION OF THE COMPLEMENT FACTOR-H BINDING-SITE ON STREPTOCOCCAL M6 PROTEIN [J].
FISCHETTI, VA ;
HORSTMANN, RD ;
PANCHOLI, V .
INFECTION AND IMMUNITY, 1995, 63 (01) :149-153
[10]   STREPTOCOCCAL M-PROTEIN - MOLECULAR DESIGN AND BIOLOGICAL BEHAVIOR [J].
FISCHETTI, VA .
CLINICAL MICROBIOLOGY REVIEWS, 1989, 2 (03) :285-314